KZIA
Kazia Therapeutics Limited - American Depositary Shares (KZIA)
$87
About Kazia Therapeutics Limited - American Depositary Shares (KZIA)
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
Details
Daily high
$10.90
Daily low
$9.67
Price at open
$10.03
52 Week High
$17.40
52 Week Low
$2.86
Market cap
18.2M
Dividend yield
0.00%
Volume
63,769
Avg. volume
293,986
P/E ratio
-.88
Kazia Therapeutics Limited - American Depositary Shares News
Details
Daily high
$10.90
Daily low
$9.67
Price at open
$10.03
52 Week High
$17.40
52 Week Low
$2.86
Market cap
18.2M
Dividend yield
0.00%
Volume
63,769
Avg. volume
293,986
P/E ratio
-.88